Advertisement Kos Life Sciences deploys OmniComm for series of studies - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Kos Life Sciences deploys OmniComm for series of studies

Kos Life Sciences, a subsidiary of New Jersey-based Kos Pharmaceuticals, has employed Davie, Florida-based OmniComm Systems to provide electronic data capture service and support for a series of up to ten phase I trials in 2005.

The firm will use OmniComm’s TrialMaster phase I application to collect data at phase I in-patient units. Laboratory data will be imported into the application in an attempt to allow normal range verification, query laboratory data and reduce or eliminate the need to combine multiple streams of data in order to complete analysis.